Clinical Trials
The 52-week IDEAL study aims to enroll 75 patients with PBC who have an incomplete response or intolerance to ursodeoxycholic acid (UDCA), in each case
August 14, 2023
No Comments
Blog
Category: Clinical Trials
- Home
- Category: Clinical Trials
Clinical Trials
Ipsen and GENFIT announce positive topline data from the pivotal ELATIVE Phase III trial. In the trial the efficacy and safety of elafibranor, an investigational
June 30, 2023
No Comments
Clinical Trials
Intercept Pharmaceuticals announces new data showing potential of Fixed-Dose Combination of OCA and Bezafibrate to normalize multiple biomarkers in PBC to be featured in podium
June 11, 2023
No Comments
Clinical Trials
The GLISTEN clinical trial is investigating a potential new treatment specifically for PBC itch and is now enrolling patients worldwide. In Canada, the study is
May 31, 2023
No Comments
Clinical Trials
Intercept Pharmaceuticals is investigating a fixed-dose combination of OCA and bezafibrate for the potential treatment of individuals with PBC. Clinical trials are underway to establish
May 18, 2023
No Comments
Clinical Trials
The Phase 2 PACIFIC study will enroll approximately 58 patients with moderate-to-severe pruritus due to PBC or PSC. Now enrolling in Canada, see what’s involved
March 1, 2023
No Comments
A study published in the Gastroenterology (September 2022) showed that people receiving OCA for primary biliary cholangitis (PBC) in a clinical trial setting had greater
February 18, 2023
No Comments
“This study demonstrates the significant anticholestatic effects of seladelpar in patients with PBC who had suboptimally responded to UDCA or were UDCA intolerant. Evidence of
August 19, 2022
No Comments
New analyses of clinical studies of Seladelpar were presented during Digestive Disease Week® (DDW) in San Diego on May 23, 2022. The three presentations were:
May 24, 2022
No Comments
Clinical Trials
The purpose of this clinical research study is to evaluate the effects of an investigational product (setanaxib) as a potential additional treatment for PBC. The
April 7, 2022
No Comments